One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Factory Location: 3 Block,No.333 Hanyang Road, Shizhong District, 641000, Neijiang City, Shizhong, China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Payment Terms: T/T
Ingredients: Active ingredient: docetaxel Molecular formula: C43H53NO14Molecular weight: 807.88Excipients: polysorbate 80, anhydrous citric acid and absolute ethanol. Properties: This product is colorless to brownish yellow clear liquid. Indications: breast cancer1. It is suitable for the treatment of locally advanced or metastatic breast cancer.2. Docetaxel combined with trastuzumab is used for the treatment of patients with metastatic breast cancer with overexpression of HER 2 gene, who have not received chemotherapy for metastatic cancer in the early stage.3. Docetaxel combined with doxorubicin and cyclophosphamide is used for postoperative adjuvant chemotherapy in patients with node-positive breast cancer.Non-small cell lung cancerIndicated for the treatment of locally advanced or metastatic non-small cell lung cancer, even after failure of cisplatin-based chemotherapy.prostate cancerDocetaxel in combination with prednisone or prednisolone is used to treat hormone-refractory metastatic prostate cancer.gastric cancerDocetaxel in combination with cisplatin and 5-fluorouracil (TCF regimen) is used to treat advanced gastric adenocarcinoma that has not previously received chemotherapy, including gastroesophageal junction adenocarcinoma. Dosage: Docetaxel can only be used for intravenous infusion.
Audited Supplier
Pharma Sources Insight January 2025
